SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 6.56 |
| Enterprise Value ($M) | 3.39 |
| Book Value ($M) | 3.68 |
| Book Value / Share | 0.24 |
| Price / Book | 1.78 |
| NCAV ($M) | 1.71 |
| NCAV / Share | 0.11 |
| Price / NCAV | 3.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.58 |
| Return on Assets (ROA) | -1.12 |
| Return on Equity (ROE) | -1.48 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.72 |
| Current Ratio | 1.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.78 |
| Assets | 6.75 |
| Liabilities | 3.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.11 |
| Operating Income | -15.09 |
| Net Income | -14.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -14.65 |
| Cash from Investing | 0.82 |
| Cash from Financing | 1.44 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Nikko Asset Management Americas, Inc. | 0.00 | -100.00 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 19,787 | 88,608 | 22.33 | |
| 86,893 | 288,510 | 30.12 | |
| 49,453 | 331,376 | 14.92 | |
| 44,115 | 153,223 | 28.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ONCO – Onconetix, Inc. | ONCT – Oncternal Therapeutics, Inc. |
| ONCY – Oncolytics Biotech Inc. | ORGO – Organogenesis Holdings Inc. |
| ORMP – Oramed Pharmaceuticals Inc. |